Search Results
97 results
Your search is now limited to «Clinical Trials» expert search.
PR Newswire 02/20/2019 06:55
The FDA has placed the trial on partial clinical hold pending review of additional details regarding these events, safety and efficacy information across the study, and satisfactory review of amendments to the study protocol and related documents.
More from PR Newswire:
Healio News 02/20/2019 06:00
The NIH announced the start of a clinical trial that will explore the preference among adolescent girls and young women between pre-exposure prophylaxis, or PrEP, and a vaginal ring for HIV prevention.
More from Healio News:
WN.com 02/20/2019 04:56
Montana cancer patient first person chosen for clinical trial Germaine Stivers’ journey with cancer has taken her to a place where no one has gone before.
More from WN.com:
ClinicalTrials.gov 02/19/2019 09:10
Condition : Systemic Lupus Erythematosus Interventions : Drug: Placebo; Drug: PF-06700841 15 mg; Drug: PF-06700841 30 mg; Drug: PF-06700841 45 mg Sponsor : Pfizer Not yet recruiting.
More from ClinicalTrials.gov:
GlobeNewswire 02/19/2019 06:00
Moreover, results from a Phase 2b clinical trial demonstrated that leronlimab monotherapy can prevent viral escape in HIV-infected patients, with some patients on leronlimab monotherapy remaining virally suppressed for more than four years.
More from GlobeNewswire:
Asanas lead asset for immunology/dermatology indications – ASN002, a novel dual inhibitor of JAK and SYK kinases – is in Phase 2b development in moderate-to-severe atopic dermatitis patients (RADIANT study – NCT03654755.
More from Global Banking & Finance Review:
Immuno-Oncology News 02/12/2019 08:00
The open-label Phase 1 JAVELIN Solid Tumor trial (NCT01772004) was designed to study the safety and efficacy of Bavencio across multiple cancer types.
More from Immuno-Oncology News:
BioNewsFeeds 02/11/2019 12:57
Sanofi is conducting other three Phase 3 trials assessing isatuximab in combination with standard treatments for patients with multiple myeloma.
More from BioNewsFeeds:
The late-stage pipeline advanced significantly in 2018, with four compounds moving into Phase 3 clinical development.
More from Middle East North Africa Financial Network (MENAFN):
Benzinga 02/04/2019 07:05
In addition, clinical trials may not confirm any safety, potency or other product characteristics described or assumed in this press release.
More from Benzinga:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications